New England Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.22M Buy
68,367
+1,042
+2% +$120K 1.05% 24
2025
Q4
$7.09M Buy
67,325
+1,775
+3% +$167K 0.93% 33
2025
Q3
$5.5M Buy
65,550
+13,400
+26% +$1.1M 0.72% 44
2025
Q2
$4.13M Buy
52,150
+6,855
+15% +$545K 0.64% 55
2025
Q1
$4.07M Buy
45,295
+14,015
+45% +$1.31M 0.66% 54
2024
Q4
$3.11M Sell
31,280
-6,075
-16% -$626K 0.53% 66
2024
Q3
$4.24M Buy
37,355
+1,085
+3% +$129K 0.66% 55
2024
Q2
$4.49M Sell
36,270
-895
-2% -$115K 0.75% 52
2024
Q1
$4.9M Sell
37,165
-14,285
-28% -$1.76M 0.76% 50
2023
Q4
$5.61M Sell
51,450
-5,925
-10% -$615K 0.9% 37
2023
Q3
$5.91M Sell
57,375
-2,700
-4% -$291K 0.97% 37
2023
Q2
$6.93M Hold
60,075
1.01% 31
2023
Q1
$6.39M Sell
60,075
-16,940
-22% -$1.83M 0.95% 38
2022
Q4
$8.54M Sell
77,015
-3,270
-4% -$334K 0.16% 28
2022
Q3
$6.91M Sell
80,285
-15,357
-16% -$1.37M 0.12% 30
2022
Q2
$8.72M Buy
95,642
+1,747
+2% +$155K 0.15% 26
2022
Q1
$7.7M Sell
93,895
-430
-0.5% -$33.9K 0.12% 34
2021
Q4
$7.23M Buy
94,325
+5,160
+6% +$411K 0.11% 30
2021
Q3
$6.7M Buy
89,165
+19,800
+29% +$1.51M 0.12% 28
2021
Q2
$5.39M Sell
69,365
-1,967
-3% -$146K 0.1% 37
2021
Q1
$5.25M Buy
71,332
+3,825
+6% +$282K 0.1% 38
2020
Q4
$5.27M Buy
67,507
+1,624
+2% +$124K 0.11% 35
2020
Q3
$5.21M Sell
65,883
-2,462
-4% -$193K 0.13% 32
2020
Q2
$5.04M Sell
68,345
-5,974
-8% -$450K 0.12% 29
2020
Q1
$5.46M Buy
74,319
+4,381
+6% +$344K 0.13% 28
2019
Q4
$6.07M Sell
69,938
-943
-1% -$77.5K 0.1% 25
2019
Q3
$5.69M Hold
70,881
0.11% 31
2019
Q2
$5.67M Sell
70,881
-839
-1% -$64.2K 0.11% 29
2019
Q1
$5.69M Buy
71,720
+2,872
+4% +$215K 0.11% 27
2018
Q4
$5.02M Buy
68,848
+2,724
+4% +$192K 0.11% 28
2018
Q3
$4.48M Buy
66,124
+152
+0.2% +$9.68K 0.08% 37
2018
Q2
$3.82M Buy
65,972
+7,074
+12% +$399K 0.07% 37
2018
Q1
$3.06M Buy
58,898
+4,612
+8% +$249K 0.06% 46
2017
Q4
$2.91M Buy
54,286
+314
+0.6% +$17.4K 0.06% 53
2017
Q3
$3.3M Buy
53,972
+210
+0.4% +$12.7K 0.07% 39
2017
Q2
$3.29M Sell
53,762
-1,677
-3% -$102K 0.11% 36
2017
Q1
$3.36M Buy
55,439
+3,689
+7% +$224K 0.06% 39
2016
Q4
$2.91M Buy
51,750
+1,781
+4% +$104K 0.08% 38
2016
Q3
$2.98M Hold
49,969
0.11% 36
2016
Q2
$2.75M Buy
49,969
+315
+0.6% +$16.8K 0.1% 42
2016
Q1
$2.51M Sell
49,654
-6,414
-11% -$314K 0.08% 45
2015
Q4
$2.83M Buy
56,068
+17,187
+44% +$867K 0.07% 40
2015
Q3
$1.83M Buy
38,881
+3,144
+9% +$167K 0.05% 90
2015
Q2
$1.94M Buy
35,737
+943
+3% +$52.9K 0.05% 82
2015
Q1
$1.91M Sell
34,794
-4,213
-11% -$239K 0.05% 88
2014
Q4
$2.11M Hold
39,007
0.05% 76
2014
Q3
$2.21M Sell
39,007
-6,288
-14% -$353K 0.05% 80
2014
Q2
$2.5M Sell
45,295
-20,205
-31% -$1.1M 0.06% 85
2014
Q1
$3.55M Sell
65,500
-6,288
-9% -$326K 0.09% 69
2013
Q4
$3.43M Buy
71,788
+1,782
+3% +$81.5K 0.09% 73
2013
Q3
$3.18M Buy
70,006
+16,768
+31% +$766K 0.09% 70
2013
Q2
$2.36M Buy
+53,238
New +$2.38M 0.07% 73

Other funds holding MRK

New England Asset Management's MRK Position: Q1 2026 in Review

New England Asset Management increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $120K and bringing the position to 68,367 shares worth $8.22M. The position accounts for 1.05% of the portfolio, ranked #24.

New England Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.72M in Q2 2022. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • New England Asset Management held 68,367 shares of Merck worth $8.22M as of Q1 2026.
  • New England Asset Management bought 1,042 Merck shares in Q1 2026, an estimated $120K.
  • Merck made up 1.05% of New England Asset Management's portfolio in Q1 2026, its #24 holding.
  • New England Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • New England Asset Management's Merck position peaked at $8.72M in Q2 2022.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on New England Asset Management's 13F filing for Q1 2026, filed 15 May 2026.